D&M Company Announces Consolidated Investment Asset Balance (March 2026)

D&M Company (Headquarters: Kita-ku, Osaka; Representative Director: Akiyoshi Matsushita; Securities Code: 189A) has decided to disclose its investment asset balance, one of its key management indicators, on a monthly basis to accelerate and enhance information provision to stakeholders. For March 2026, the number of bond purchasing companies decreased by one due to contract termination, totaling 101 companies at the end of March. The investment asset balance decreased by 18 million JPY due to bond purchases, and with the collection of operating loans, the total investment asset balance decreased by 29 million JPY from the previous month to 9,494 million JPY. The D&M Group provides multiple services to medical and nursing care business operators with the aim of management support. Among these, F&I (Finance & Investment) services are fundamental to supporting other services and are indispensable for the overall growth of the business, accounting for 50.1% of consolidated sales and 68.9% of gross profit in the fiscal year ending May 2025. The majority of F&I service revenue comes from commission fees for purchasing medical and nursing care claims, with revenue calculated by multiplying the claim purchase amount by a certain rate. Therefore, the company emphasizes the investment asset balance, including medical and nursing care claims, as an indicator to measure business expansion. D&M Company specializes in the medical, nursing care, and welfare service industries, providing one-stop support for critical themes such as finance, management, and human resources.